Apotex Inc., a Canadian-based global health company, announced it sourced 81% of global electricity consumption from renewable or low-carbon sources in 2024.

The company also achieved significant reductions in Scope 1 and 2 emissions through the implementation of energy-efficient technologies across its facilities.

Apotex also hired a new Head of Sustainability to advance the company’s enterprise-wise ESG strategy and seeks to continue implementing energy-efficient technologies and renewable energy solutions to further reduce its environmental footprint. 

The company — which provides generic, biosimilar, innovative branded pharmaceuticals and consumer health products — published details in its 2024 Sustainability Report, showcasing its ongoing commitment to sustainable, responsible business practices and its global impact.

“Apotex’s 2024 Sustainability Report underscores our commitment to advancing health and unlocking new possibilities through partnerships, while championing sustainability and responsible business practices. As we continue to execute our Journey of Health growth strategy, our focus on sustainability ensures that we are meeting the needs of patients, physicians, and pharmacists, and contributing positively to the environment and society. This report reflects our dedication to these values, and to transparency, accountability, and long-term value creation,” said Allan Oberman, President and CEO of Apotex, in a statement.